Selective antibody activation through protease-activated pro-antibodies that mask binding sites with inhibitory domains | Scientific Reports
The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control | ACS Central Science
A coiled-coil masking domain for selective activation of therapeutic antibodies | Nature Biotechnology
Mechanistic insights into the rational design of masked antibodies
Frontiers | Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity
The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control | ACS Central Science
The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control | ACS Central Science
Strategies to enhance monoclonal antibody uptake and distribution in solid tumors | Cancer Biology & Medicine
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody | Nature Communications
Selective antibody activation through protease-activated pro-antibodies that mask binding sites with inhibitory domains | Scientific Reports
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies - ScienceDirect
The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control | ACS Central Science
Frontiers | Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity
Steric blockade of antibody CDRs as a modular antibody masking... | Download Scientific Diagram
Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text
Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text
The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control | ACS Central Science
Ab locks for improving the selectivity and safety of antibody drugs | Journal of Biomedical Science | Full Text
Exelixis and Adagene Enter into Collaboration and License Agreement to Develop Novel Masked Antibody-Drug Conjugate Therapies with Improved Safety and Efficacy Profiles - Adagene
Exploiting protease activation for therapy - ScienceDirect
The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals | Journal of Nuclear Medicine
Overview of a Probody construct and IHZ technology. (a) A Probody... | Download Scientific Diagram
The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control | ACS Central Science
PDF) Design and development of masked therapeutic antibodies to limit off-target effects Application to anti-EGFR antibodies
